These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 1349254)

  • 41. Neurotensin receptor antagonist SR 142948A alters Fos expression and extrapyramidal side effect profile of typical and atypical antipsychotic drugs.
    Binder EB; Kinkead B; Owens MJ; Nemeroff CB
    Neuropsychopharmacology; 2004 Dec; 29(12):2200-7. PubMed ID: 15328528
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effects of amphetamine analogs on neurotensin concentrations in rat brain.
    Merchant KM; Letter AA; Johnson M; Stone DM; Gibb JW; Hanson GR
    Eur J Pharmacol; 1987 Jun; 138(1):151-4. PubMed ID: 2887434
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Time course of the antipsychotic effect and the underlying behavioral mechanisms.
    Li M; Fletcher PJ; Kapur S
    Neuropsychopharmacology; 2007 Feb; 32(2):263-72. PubMed ID: 16738541
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Endogenous neurotensin is involved in estrous cycle related alterations in prepulse inhibition of the acoustic startle reflex in female rats.
    Kinkead B; Yan F; Owens MJ; Nemeroff CB
    Psychoneuroendocrinology; 2008 Feb; 33(2):178-87. PubMed ID: 18155361
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effects of neurotensin on regional concentrations of norepinephrine in rat brain.
    Drumheller AL; St-Pierre S; Jolicoeur FB
    Brain Res Bull; 1986 May; 16(5):755-8. PubMed ID: 3742254
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Repeated administration of the neurotensin analogue NT69L induces tolerance to its suppressant effect on conditioned avoidance behaviour.
    Hertel P; Olsen CK; Arnt J
    Eur J Pharmacol; 2002 Mar; 439(1-3):107-11. PubMed ID: 11937099
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Regional, reversible ultrastructural changes in rat brain with chronic neuroleptic treatment.
    Meshul CK; Casey DE
    Brain Res; 1989 Jun; 489(2):338-46. PubMed ID: 2568156
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effects of chronic haloperidol and clozapine treatment on neurotensin and c-fos mRNA in rat neostriatal subregions.
    Merchant KM; Dobie DJ; Filloux FM; Totzke M; Aravagiri M; Dorsa DM
    J Pharmacol Exp Ther; 1994 Oct; 271(1):460-71. PubMed ID: 7965747
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The quetiapine active metabolite N-desalkylquetiapine and the neurotensin NTS₁ receptor agonist PD149163 exhibit antidepressant-like effects on operant responding in male rats.
    Hillhouse TM; Shankland Z; Matazel KS; Keiser AA; Prus AJ
    Exp Clin Psychopharmacol; 2014 Dec; 22(6):548-56. PubMed ID: 25285844
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Reversal of sensorimotor gating deficits in Brattleboro rats by acute administration of clozapine and a neurotensin agonist, but not haloperidol: a potential predictive model for novel antipsychotic effects.
    Feifel D; Melendez G; Shilling PD
    Neuropsychopharmacology; 2004 Apr; 29(4):731-8. PubMed ID: 14760394
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Neurotensin-deficient mice show altered responses to antipsychotic drugs.
    Dobner PR; Fadel J; Deitemeyer N; Carraway RE; Deutch AY
    Proc Natl Acad Sci U S A; 2001 Jul; 98(14):8048-53. PubMed ID: 11427716
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Differential induction of neurotensin and c-fos gene expression by typical versus atypical antipsychotics.
    Merchant KM; Dorsa DM
    Proc Natl Acad Sci U S A; 1993 Apr; 90(8):3447-51. PubMed ID: 8097317
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Chronic continuous or intermittent infusion of cocaine differentially alter the concentration of neurotensin-like immunoreactivity in specific rat brain regions.
    Cain ST; Griff D; Joyner CM; Ellinwood EH; Nemeroff CB
    Neuropsychopharmacology; 1993 May; 8(3):259-65. PubMed ID: 8507352
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effects of chronic treatment of olanzapine and haloperidol on peptide YY binding densities in the rat brain.
    Wang Q; Huang XF
    Exp Neurol; 2008 Jan; 209(1):261-7. PubMed ID: 18022161
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Clozapine, but not haloperidol, increases brain concentrations of neuroactive steroids in the rat.
    Barbaccia ML; Affricano D; Purdy RH; Maciocco E; Spiga F; Biggio G
    Neuropsychopharmacology; 2001 Oct; 25(4):489-97. PubMed ID: 11557162
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The effect of chronic atypical antipsychotic drugs and haloperidol on amphetamine-induced dopamine release in vivo.
    Ichikawa J; Meltzer HY
    Brain Res; 1992 Mar; 574(1-2):98-104. PubMed ID: 1379112
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Widespread expression of Fos protein induced by acute haloperidol administration in the rat brain.
    Suzuki M; Sun YJ; Murata M; Kurachi M
    Psychiatry Clin Neurosci; 1998 Jun; 52(3):353-9. PubMed ID: 9681590
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Dopamine and neurotensin storage in colocalized and noncolocalized neuronal populations.
    Bean AJ; Adrian TE; Modlin IM; Roth RH
    J Pharmacol Exp Ther; 1989 Jun; 249(3):681-7. PubMed ID: 2732943
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Changes in [
    Rosin C; López Ordieres MG; Rodríguez de Lores Arnaiz G
    Peptides; 2017 Mar; 89():82-89. PubMed ID: 27586561
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Haloperidol and apomorphine differentially affect neuropeptidase activity.
    Waters SM; Konkoy CS; Davis TP
    J Pharmacol Exp Ther; 1996 Apr; 277(1):113-20. PubMed ID: 8613907
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.